A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice

PURPOSE: For the first-line treatment of KRAS mutant non-small cell lung cancer (NSCLC) patients, immunotherapy or platinum-based chemotherapy are the main treatment method. Here, we investigated the clinical efficacy and prognosis those two regimens as first-line treatment in real-world practice. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanxia, Gao, Yuan, Wang, Ying, Zhao, Cong, Zhang, Zhiyun, Li, Baolan, Zhang, Tongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664628/
https://www.ncbi.nlm.nih.gov/pubmed/36376839
http://dx.doi.org/10.1186/s12885-022-10236-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664628/
https://www.ncbi.nlm.nih.gov/pubmed/36376839
http://dx.doi.org/10.1186/s12885-022-10236-9

Ejemplares similares